Kissling E, et al. Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019. Euro Surveill. 2019 Feb;24(8).
Influenza A(H1N1)pdm09 and A(H3N2) viruses both circulated in Europe in October 2018-January 2019. Interim results from six studies indicate that 2018/19 influenza vaccine effectiveness (VE) estimates among all ages in primary care was 32-43% against influenza A; higher against A(H1N1)pdm09 and lower against A(H3N2). Among hospitalised older adults, VE estimates were 34-38% against influenza A and slightly lower against A(H1N1)pdm09. Influenza vaccination is of continued benefit during the ongoing 2018/19 influenza season.
See Also:
Latest articles in those days:
- The Limited Role for Antiviral Therapy in Influenza 36 minute(s) ago
- Pathogenesis of bovine H5N1 clade 2.3.4.4b infection in Macaques 1 hours ago
- [preprint]Susceptibility of bovine respiratory and mammary epithelial cells to avian and mammalian derived clade 2.3.4.4b H5N1 highly pathogenic avian influenza viruses 1 days ago
- Genetic Diversity of H10N3 Avian Influenza Virus Isolated from Anhui Province, China 1 days ago
- Molecular origion of human infection with a novel avian influenza A H10N3 virus in China, 2021 1 days ago
[Go Top] [Close Window]
